Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation

2024-9-12

Point-of-Care CAR-T Manufacturing Solutions: Can One Model Fit All?

2024-9-12

Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy

2024-9-12

Tin E, Lee JB, Khatri I, et al. Double-negative T cells utilize a TNFα–JAK1–ICAM-1 cytotoxic axis against acute myeloid leukemia. <i>Blood Adv.</i> 2024;8(12):3013-3026.

2024-9-12

Joseph JM, Hillengass J, Tang L, et al. Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population. <i>Blood Adv.</i> 2024;8(3):538-548.

2024-9-10

Ancestry-Independent Risk of Venous Thromboembolism in Individuals with Sickle Cell Trait vs. Factor V Leiden

2024-9-10

A boost for poor graft function

2024-9-10

Myo1c drives actin-dependent VWF expulsion from EC WPBs

2024-9-10

Prophylactic VSTs: a promising start but still work to do

2024-9-10

A Multicenter Phase II Clinical Trial of Low-Dose Subcutaneous Decitabine in Myelofibrosis

2024-9-9

In Vivo Silencing of Intestinal DMT1 Mitigates Iron Loading in β-thalassemia Intermedia (Hbbth3/+) Mice

2024-9-9

Plasmin Generation Analysis in Patients with Bleeding Disorder of Unknown Cause

2024-9-4

Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice

2024-9-3

Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer associated fibroblasts

2024-9-3

Thromboinflammation is associated with clinical outcome after ST-elevation myocardial infarction

2024-9-3

Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study

2024-8-30

Evaluation of prognostic factors for high-risk classical Hodgkin lymphoma undergoing autologous transplantation

2024-8-30

Magrolimab Plus Rituximab in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Phase 1/2 Trial 3-Year Follow-up

2024-8-30

Local Radiation Enhances Systemic CAR T Cell Efficacy by Augmenting Antigen Cross-Presentation and T-cell Infiltration

2024-8-30

The duration of iron deficiency burden

2024-8-29

The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial

2024-8-29

NFAT5 counters long-term IFN-I responses in hematopoietic stem cells to preserve reconstitution potential

2024-8-29

Comparison of patients with myeloma receiving zoledronic acid versus denosumab: A nationwide retrospective cohort study

2024-8-29

Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with R/R B-ALL : A GRAALL study from the DESCAR-T registry

2024-8-29

Thrombomodulin (p.Cys537Stop) is released from cells by an unusual membrane insertion/leakage mechanism

2024-8-29

Biomarker-derived Fast-and-frugal decision tree for preemption of Veno-occlusive Disease/Sinusoidal obstructive syndrome

2024-8-29

Interleukin-1β, <i>JAK2</i>V617F mutation and inflammation in MPNs

2024-8-27

Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis

2024-8-27

Consensus Recommendations for Severe Aplastic Anemia

2024-8-27

Risk of hospitalization with infection in adults with primary AIHA treated with rituximab: a French nationwide study

2024-8-27

Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population–based analysis

2024-8-27

Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric Immune Thrombocytopenia

2024-8-27

Impact of Iron Overload on Incidence of Diabetes Mellitus, Cardiac Disease, and Death in Congenital Hemolytic Anemias

2024-8-27

Ending endless follow-up for low-risk CLL?

2024-8-27

Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial

2024-8-27

Metformin for MPN: teaching an old drug new tricks

2024-8-27

High-Grade B-Cell Lymphoma, Not Otherwise Specified: CNS Involvement and Outcomes in a Multi-Institutional Series

2024-8-27

An αIIbβ3 monoclonal antibody traps a semiextended conformation and allosterically inhibits large ligand binding

2024-8-27

Doubling down on PK activation for sickle cell disease

2024-8-27

Cardiac Events after Allo-HCT in Patients with Acute Myeloid Leukemia. Study Conducted con Behalf of the GETH-TC

2024-8-23

COVID-19 Vaccination During Therapy in Relation to COVID-19 Death in CLL

2024-8-22

Health-Related Quality of Life with Gilteritinib versus Placebo Post-Transplant for FLT3-ITD+ Acute Myeloid Leukemia

2024-8-21

Evolving consolidation patterns and outcomes for a large cohort of primary CNS lymphoma patients

2024-8-21

Decreasing Chronic Graft-Versus-Host Disease rates in all populations

2024-8-21

Haploidentical versus HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations

2024-8-21

Proactive Systematic Hemophilia Carrier Screening: A Step Towards Gender Equity in Hemophilia Care

2024-8-21

Chemokine receptors are required for effector T cell trafficking to GVHD tissues but not to bone marrow

2024-8-21

Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation

2024-8-19

NUP98 is Rearranged in 5.0% of Adult East-Asian AML Patients

2024-8-16

Dalby A, Mezzano D, Rivera J, et al. Introduction of an ancient founder glycoprotein VI mutation into the Chilean population. <i>Blood Adv</i>. 2022;6(22):5866-5869.

2024-8-16